Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial

• URL: http://arxiv.org/abs/2405.18327v1
• Date: Tue, 28 May 2024 16:21:20 GMT
• Title: Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial
• Authors: Jay Jasti, Hua Zhong, Vandana Panwar, Vipul Jarmale, Jeffrey Miyata, Deyssy Carrillo, Alana Christie, Dinesh Rakheja, Zora Modrusan, Edward Ernest Kadel III, Niha Beig, Mahrukh Huseni, James Brugarolas, Payal Kapur, Satwik Rajaram,
• Abstract summary: We present a novel deep learning (DL) approach to predict the Angioscore from ubiquitous histopathology slides. Our model produces a visual vascular network which is the basis of the model's prediction. Our approach offers insights into angiogenesis biology and AA treatment response.
• Score: 0.6087644423424302
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Predictive biomarkers of treatment response are lacking for metastatic clear cell renal cell carcinoma (ccRCC), a tumor type that is treated with angiogenesis inhibitors, immune checkpoint inhibitors, mTOR inhibitors and a HIF2 inhibitor. The Angioscore, an RNA-based quantification of angiogenesis, is arguably the best candidate to predict anti-angiogenic (AA) response. However, the clinical adoption of transcriptomic assays faces several challenges including standardization, time delay, and high cost. Further, ccRCC tumors are highly heterogenous, and sampling multiple areas for sequencing is impractical. Here we present a novel deep learning (DL) approach to predict the Angioscore from ubiquitous histopathology slides. To overcome the lack of interpretability, one of the biggest limitations of typical DL models, our model produces a visual vascular network which is the basis of the model's prediction. To test its reliability, we applied this model to multiple cohorts including a clinical trial dataset. Our model accurately predicts the RNA-based Angioscore on multiple independent cohorts (spearman correlations of 0.77 and 0.73). Further, the predictions help unravel meaningful biology such as association of angiogenesis with grade, stage, and driver mutation status. Finally, we find our model can predict response to AA therapy, in both a real-world cohort and the IMmotion150 clinical trial. The predictive power of our model vastly exceeds that of CD31, a marker of vasculature, and nearly rivals the performance (c-index 0.66 vs 0.67) of the ground truth RNA-based Angioscore at a fraction of the cost. By providing a robust yet interpretable prediction of the Angioscore from histopathology slides alone, our approach offers insights into angiogenesis biology and AA treatment response.

Related papers

• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• Using Pre-training and Interaction Modeling for ancestry-specific disease prediction in UK Biobank [69.90493129893112]
  Recent genome-wide association studies (GWAS) have uncovered the genetic basis of complex traits, but show an under-representation of non-European descent individuals. Here, we assess whether we can improve disease prediction across diverse ancestries using multiomic data.
  arXiv  Detail & Related papers  (2024-04-26T16:39:50Z)
• Prediction of Breast Cancer Recurrence Risk Using a Multi-Model Approach Integrating Whole Slide Imaging and Clinicopathologic Features [0.6679306163028237]
  The aim of this study was to develop a multi-model approach integrating the analysis of whole slide images and clinicopathologic data to predict associated breast cancer recurrence risks. The proposed novel methodology uses convolutional neural networks for feature extraction and vision transformers for contextual aggregation.
  arXiv  Detail & Related papers  (2024-01-28T23:33:56Z)
• Predicting Ovarian Cancer Treatment Response in Histopathology using Hierarchical Vision Transformers and Multiple Instance Learning [2.0661578265672094]
  Deep learning can be used to predict whether a course of treatment could contribute to remission or prevent disease progression in ovarian cancer patients. Our approach used a pretrained Hierarchical Image Pyramid Transformer (HIPT) to extract region-level features and an attention-based multiple instance learning (ABMIL) model to aggregate features and classify whole slides. It is not yet clear whether ovarian cancer WSIs contain information that can be used to accurately predict treatment response, with further validation using larger, higher-quality datasets required.
  arXiv  Detail & Related papers  (2023-10-19T16:16:29Z)
• Neural Network-Based Histologic Remission Prediction In Ulcerative Colitis [38.150634108667774]
  Histologic remission is a new therapeutic target in ulcerative colitis (UC) Endocytoscopy (EC) is a novel ultra-high magnification endoscopic technique. We propose a neural network model that can assess histological disease activity in EC images.
  arXiv  Detail & Related papers  (2023-08-28T15:54:14Z)
• Learning to diagnose cirrhosis from radiological and histological labels with joint self and weakly-supervised pretraining strategies [62.840338941861134]
  We propose to leverage transfer learning from large datasets annotated by radiologists, to predict the histological score available on a small annex dataset. We compare different pretraining methods, namely weakly-supervised and self-supervised ones, to improve the prediction of the cirrhosis. This method outperforms the baseline classification of the METAVIR score, reaching an AUC of 0.84 and a balanced accuracy of 0.75.
  arXiv  Detail & Related papers  (2023-02-16T17:06:23Z)
• SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction [68.8204255655161]
  We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data. Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
  arXiv  Detail & Related papers  (2022-04-20T17:28:08Z)
• Predicting Molecular Phenotypes with Single Cell RNA Sequencing Data: an Assessment of Unsupervised Machine Learning Models [0.0]
  This study is to evaluate unsupervised machine learning on classifying treatment-resistant phenotypes in heterogeneous tumors. scRNAseq quantifies mRNA in cells and characterizes cell phenotypes. clusters generated from this pipeline can be used to understand cancer cell behavior and malignant growth.
  arXiv  Detail & Related papers  (2021-08-11T05:30:37Z)
• Bootstrapping Your Own Positive Sample: Contrastive Learning With Electronic Health Record Data [62.29031007761901]
  This paper proposes a novel contrastive regularized clinical classification model. We introduce two unique positive sampling strategies specifically tailored for EHR data. Our framework yields highly competitive experimental results in predicting the mortality risk on real-world COVID-19 EHR data.
  arXiv  Detail & Related papers  (2021-04-07T06:02:04Z)
• Predicting Hyperkalemia in the ICU and Evaluation of Generalizability and Interpretability [5.9854349801427285]
  Hyperkalemia is a potentially life-threatening condition that can lead to fatal arrhythmias. We developed predictive models to identify intensive care unit (ICU) patients at risk of developing hyperkalemia. Our models were able to predict hyperkalemia with an AUC of (i) 0.79, 0.81, 0.81 and (ii) 0.81, 0.85, 0.85 for LR, RF, and XGBoost respectively.
  arXiv  Detail & Related papers  (2021-01-16T12:35:27Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.